Preterm premature rupture of membranes (PPROM) is often associated with intra-amniotic inflammation and infection. Current understanding of the pathogenesis of PPROM includes activation of pro-inflammatory cytokines and proteolytic enzymes leading to compromise of membrane integrity. The impact of exposure to bacterial pathogens, including Ureaplasma parvum, on gestational membranes is poorly understood. Our objective was to develop a dual-chamber system to characterize the inflammatory response of gestational membranes to U. parvum in a directional nature. Full-thickness human gestational membrane explants, with either choriodecidua or amnion oriented superiorly, were suspended between two washers in a cylindrical device, creating two distinct compartments. Brilliant green dye was introduced into the top chamber to assess the integrity of the system. Tissue viability was evaluated after 72 h using a colorimetric cell proliferation assay. Choriodecidua or amnion was exposed to three doses of U. parvum and incubated for 24 h. Following treatment, media from each compartment were used for quantification of U. parvum (quantitative PCR), interleukin (IL)-8 (enzyme-linked immunosorbent assay), and matrix metalloproteinase (MMP)-2 and MMP-9 activity (zymography). We observed that system integrity and explant viability were maintained over 72 h. Dosedependent increases in recovered U. parvum, IL-8 concentration, and MMP-2 activity were detected in both compartments. Significant differences in IL-8 concentration and MMP-9 activity were found between the choriodecidua and amnion. This tissue explant system can be used to investigate the inflammatory consequences of directional bacterial exposure for gestational membranes and provides insight into the pathogenesis of PPROM and infectious complications of pregnancy.
INTRODUCTION
Preterm premature rupture of membranes (PPROM) represents the leading identifiable cause of preterm delivery and its attendant morbidity and mortality [1] . The etiology of PPROM is poorly understood and likely multifactorial. The working hypothesis for the mechanism underlying PPROM entails inflammatory activation of the gestational membranes leading to localized loss of membrane integrity and tensile strength. Increased levels of inflammatory cells and cytokines, including interleukin (IL)-8, are found in gestational tissues and maternal-fetal circulation of pregnancies complicated by PPROM [2] [3] [4] [5] . These inflammatory cells and cytokines are hypothesized to upregulate matrix metalloproteinases (MMPs), prostaglandins, and pro-apoptotic proteins [6] . In normal pregnancy, the tensile strength of gestational membranes demands continuous extracellular matrix remodeling and equilibrium between collagen synthesis and degradation regulated by proteolytic enzymes and their inhibitors [5] . In the setting of PPROM, MMP-2 and MMP-9 activity increases with a concomitant decrease in the activity of metalloproteinase tissue inhibitors [7, 8] . The final common pathway to PPROM includes increased proteolysis in the extracellular matrix, inflammation, and apoptosis, effecting a zone of extreme morphological alteration and ultimately leading to weakening and rupture of membranes [9] .
Intra-amniotic infection, including subclinical infection, has been proposed as a precipitant of gestational membrane inflammation and PPROM [5] . While only 1%-2% of women initially presenting with PPROM demonstrate clinical manifestations of chorioamnionitis, a far greater proportion demonstrate amniotic fluid culture or PCR assay positive for bacteria [10] [11] [12] . Moreover, gestational membranes collected from pregnancies complicated by PPROM have been found to harbor greater bacterial counts than membranes from subjects at term or with preterm labor [13] . In particular, the bacterial species Ureaplasma parvum has been implicated in adverse pregnancy outcomes including PPROM [14, 15] . The presence of U. parvum in the lower genital tract corresponds to increased microbial invasion of the amniotic cavity and histologic chorioamnionitis. Intra-amniotic U. parvum bacterial load appears to increase both localized and systemic inflammatory response [16] [17] [18] . The exact pathogenicity of U. parvum has eluded researchers for several reasons. First, U. parvum is a common commensal organism in healthy women of reproductive age, rendering challenging the delineation between colonization and infection [19, 20] . Second, the bacteria are often found as part of a polymicrobial infection or in conjunction with other disturbances to the vaginal microbiological environment, that is, bacterial vaginosis [21] . Addi-tionally, the species U. parvum and Ureaplasma urealyticum have only recently been recognized as having different pathogenicity with the former being more strongly associated with PPROM [22, 23] .
Current understanding of the inflammatory response of gestational membranes to bacteria has predominantly relied on experimentation with cultured cells of the amnion, chorion, and decidua. Alternatively, the use of tissue explants affords the advantage of preservation of the barrier mechanism of the intact membranes and the paracrine and autocrine ramifications for cells across the membrane layers. Several models have been utilized to study intact gestational membranes ex vivo [24] [25] [26] [27] [28] [29] . By mounting explants across various support devices, two distinct compartments-maternal and fetal-are created, thus allowing the assessment of directionality of the inflammatory response of gestational membranes. These systems provide a method for examining the consequences of infectious insults from different sources, including ascending or transplacental infection [30] . However, these systems have required that the explant be stretched across the frame of the device in order to be secured with an elastic band. The force necessary for assembly may be nonphysiologic or inconsistent across devices and thus influence biochemical signaling and confound interpretation of inflammation in the tissues.
The objectives of this study included the development and validation of a dual-chamber system for experimentation with intact gestational membrane explants. We designed this model with the goal of consistent and limited amount of membrane tension required to secure and maintain explants within the devices. Characteristics desired for this model were assembly without leakage from one compartment to the other and preservation of tissue viability. Using this novel system, we sought to understand the consequences of U. parvum exposure for gestational membranes in a directional fashion. In particular, we tested the directionality of U. parvum translocation across the gestational membranes. We further determined the extent to which U. parvum provokes an inflammatory response, as indicated by upregulated IL-8 levels and enhanced MMP-2 and MMP-9 proteolytic activity as well as the polarity of the response with exposure of the choriodecidua or amnion to U. parvum. We chose to evaluate these analytes because production of IL-8 and enzymatic degradation of collagen by MMP-2 and MMP-9 likely represent important steps in intra-amniotic inflammation leading to PPROM. Ultimately, we hope to contribute to scientific understandings of the pathogenicity of U. parvum and its role in inflammation of gestational membranes and PPROM.
MATERIALS AND METHODS

Ethics Statement
This research protocol was evaluated and approved by the Duke University Institutional Review Board and was considered exempt from review because no identifiable health information was to be recorded and gestational membranes were otherwise to be discarded following delivery.
Clinical Specimens
The gestational membranes of 10 subjects were collected following scheduled, uncomplicated Cesarean delivery without labor or rupture of membranes. Information regarding subject demographics and clinical outcomes was not collected. Full-thickness gestational membranes including amnion, chorion, and decidua were excised from the placenta within 5 min after delivery and transported to the laboratory at room temperature in tissue culture medium consisting of Dulbecco modified Eagle medium: nutrient mixture F-12 (Life Technologies) containing 10% fetal bovine serum (Life Technologies) and 100 units/ml penicillin, 100 lg/ml streptomycin, and 250 ng/ml amphotericin B (antibiotic-antimycotic; Life Technologies).
Tissue Preparation and Model Assembly
Within 30 min after delivery, gestational membranes were washed three times with room-temperature tissue culture medium to remove adherent blood. Membranes were visually inspected for integrity of amnion and choriodecidua. Using a disk cutter, circular disks of 2 cm diameter were prepared from the intact membranes. Disks were not excised from the specimen in a systematic manner nor was the relative distance from the cervix or site of membrane rupture known. Each disk was positioned without tension between two rubber washers (Ace Hardware) and secured in a cylindrical stainless steel device (Ace Hardware) creating two distinct compartments (Fig. 1) . Each device was placed in a single well of a six-well tissue culture plate to allow culture medium to be in contact with either the upward-oriented or downward-oriented layer of the gestational membranes. Culture medium containing reduced fetal bovine serum (1%; Life Technologies) was added to each superior compartment (2 ml) and each inferior compartment (4 ml). A disk of aluminum mesh was placed at the bottom of each well to ensure adequate circulation of the media in the inferior compartment. Membranes were incubated at 378C and 5% CO 2 .
Integrity of the system was assessed in preliminary studies in three devices (n ¼ 3 subjects). Brilliant green dye solution (100 lg/ml; Sigma-Aldrich) was introduced to each superior compartment, and leakage of dye to the inferior compartments was visually assessed after 72 h. Sustained viability was evaluated using three additional devices (n ¼ 3 subjects) using the colorimetric CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega) following the manufacturer's instructions. Following 72 h incubation, culture media was exchanged for phenol red-free media, and 200 ll/ml assay mixture was added to each compartment. Membranes were incubated at 378C and 5% CO 2 for 4 h with hourly mechanical agitation. Color change from yellow to brown in the media of each compartment, which indicates metabolic activity, was visually assessed.
Bacterial Culture
A fully sequenced genital isolate of U. parvum, strain 700970, was obtained from the American Type Culture Collection. The 10B medium consisting of PPLO broth (BD) supplemented with equine serum (20%; Hyclone), yeast extract (1%; BD), urea (0.1%; Sigma-Aldrich), isovitalex (250 lg/ml; BD), Lcysteine (100 lg/ml; Acros Organics), ampicillin (100 lg/ml; Sigma-Aldrich), and phenol red (10 lg/ml; Affymetrix USB) was prepared and titrated to pH 6. U. parvum was cultured in 10B medium for 24 h, harvested by centrifugation (20 000 relative centrifugal force, 48C), and resuspended in tissue culture medium for tissue treatment.
Tissue Treatment and Harvest
For each subject, eight devices were prepared, for a total of 80 devices. In half of the devices, the choriodecidua was oriented superiorly (representing the maternal compartment), and in the other half, the amnion was oriented superiorly (representing the fetal compartment). Devices containing tissue explants were equilibrated for 48 h at 378C and 5% CO 2 with medium exchanges every 24 h. Following equilibration, the superior compartment, either choriodecidua or amnion, was treated with three doses of U. parvum or served as an untreated control. In detail, existing tissue culture medium in the superior compartment was replaced with 2 ml tissue culture medium containing increasing 10-fold doses of U. parvum. These doses were previously quantified to contain 10 5 , 10 6 , or 10 7 colony-forming units (CFU) of U. parvum. Untreated controls received fresh tissue culture media without U. parvum. At the same time, the media in all inferior compartments were exchanged for fresh tissue culture media. Membranes were incubated at 378C and 5% CO 2 , and all media and tissues were harvested 24 h after treatment. Media was immediately centrifuged after which a pellet could be observed (30 min, 13 000 RPM, 48C). The pellets and supernatants were frozen separately at À808C for subsequent quantification of U. parvum and measurement of IL-8 concentration and MMP activity. A portion of the tissue culture medium containing U. parvum that was used for treatment was processed and frozen in this same manner in order to later serve as a positive PCR control.
Quantification of U. parvum by PCR
Pellets were washed with 500 ll phosphate-buffered saline (PBS) followed by centrifugation (30 min, 13 000 RPM, 48C) and removal of the supernatant. Pellets were then resuspended in 100 ll RNA-and DNA-free water and heated at 1008C for 10 min to lyse the cells. Following a second centrifugation (30 POTTS ET AL. min, 13 000 RPM, 48C), supernatant was again removed and pellets were resuspended in 100 ll purified water for quantification.
The UreB urease gene is found as a conserved single copy in the U. parvum genome and was quantified by real-time quantitative dye intercalation PCR. Master mix contained Apex buffer I (Genesee Scientific), MgCl 2 , dNTPs, Taq DNA polymerase (Invitrogen), Evagreen (Biotium), and primers (Eurofins; forward GGACGACGTTTCGATATTCC and reverse AC CTCAAACTTCGCGTGTTC). Positive controls consisted of inoculation media containing 10 7 CFU U. parvum. PCR was performed in an iCycler with an optical module (Bio-Rad). Bacterial genome copy numbers were quantified using the 2 ÀDCT algorithm by comparison with positive controls.
Measurement of IL-8 Concentration by Enzyme-Linked Immunosorbent Assay
Sandwich enzyme-linked immunosorbent assay for IL-8 was performed using a commercially available set of reagents (BD Biosciences) following manufacturer's protocol. IL-8 standards were prepared from recombinant human IL-8 (BD Biosciences) in the range of 3.1-200 pg/ml per the instructions. Supernatants from harvested tissue culture media were diluted in assay diluent at a ratio of 1:2000; for two samples that were found to have IL-8 concentrations above the range of detection; this ratio was modified to 1:200 to 1:100 and the enzyme-linked immunosorbent assay was reperformed. Colorimetric TMB Peroxidase Substrate Solution (KPL) was introduced to wells to detect IL-8 concentration. Plates were read at 450 nm with a wavelength correction at 570 nm. Because superior compartments contained 2 ml tissue culture medium and inferior compartments contained 4 ml medium, thus making the inferior compartments twice as dilute, a correction factor of two was applied to the IL-8 concentrations in the inferior compartments.
Assessment of MMP-2 and MMP-9 Activity by Zymography
Gelatin zymography was performed to assess samples for MMP-2 and MMP-9 proteolytic activity. Novex gelatin gels and sample, running, renaturing, and developing buffers (Life Technologies) were utilized in accordance with the manufacturer's protocol [31] . A volume of 20 ll of each supernatant from harvested tissue culture media was loaded on each lane of the gels. Following preparation and development, each gel was stained with Coomassie G250 stain (Invitrogen). Gelatinolytic activities of MMP-2 and MMP-9 (represented by clear bands on the gels at 72 and 92 kDa, respectively) were quantified using ImageJ software (National Institutes of Health). Again, because superior compartments contained half as much tissue culture medium as inferior compartments, a correction factor of 2 was applied to MMP activity in the inferior compartments.
Statistical Analyses
Medians and interquartile ranges were used to describe the data because they did not follow a normal distribution. Nonparametric tests were used to examine significance. Repeated measures data across treatment groups as compared to negative controls were analyzed using Friedman tests, and differences between groups or paired data were assessed using Wilcoxon signed-rank test. Significance was assessed at a ¼ 0.05. All analyses were performed using SAS software 9.4 (SAS Institute).
RESULTS
Integrity and Viability of Gestational Membrane Explants in Assembled Devices
Brilliant green dye introduced to the superior compartment did not leak to the inferior compartment during 72 h incubation. The dye was visualized neither in the media of the inferior compartment nor in the membrane layer facing the inferior compartment. Disassembly of the systems produced explants displaying precise circles of dye without leakage across the tissue adjacent to the site of dye exposure. 
RESPONSE OF GESTATIONAL MEMBRANES TO U. parvum
Sustained tissue viability of both choriodecidua and amnion was confirmed after 72 h as demonstrated by color change from yellow to brown in both superior and inferior compartments.
Translocation of U. parvum Across Gestational Membranes
Figures 2-6 display the U. parvum quantity, IL-8 concentration, and MMP activity in each compartment following exposure to increasing doses of U. parvum. Significance is assessed relative to the corresponding compartment of the untreated control. As expected, U. parvum was recovered from the superior compartment in a dose-dependent manner regardless of whether the choriodecidua (P , 0.001; Fig. 2A ) or amnion (P , 0.001; Fig. 2B ) was exposed to U. parvum. U. parvum translocation from the choriodecidual to the amniotic compartment was observed but was not dose dependent (P ¼ 0.34; Fig. 2A) . Conversely, translocation of U. parvum from the amniotic to the choriodecidual compartments was dose dependent (P ¼ 0.031; Fig. 2B ). U. parvum was not detected in negative PCR controls. 
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Effects of U. parvum Exposure on IL-8 Concentration in Gestational Membranes
Following exposure to U. parvum, IL-8 was detectable in both compartments. Exposure of the choriodecidual compartment to U. parvum did not result in a statistically significant dose-dependent increase in IL-8 in the choriodecidual (P ¼ 0.062) or amniotic compartment (P ¼ 0.56; Fig. 3A ). However, a dose-dependent increase in IL-8 concentrations was observed in both the amniotic and choriodecidual compartments when the amniotic compartment was exposed to increasing doses of U. parvum (P ¼ 0.002 and 0.024, respectively; Fig. 3B) . Tables 1-3 display data aggregated from all experiments (i.e., following both choriodecidual and amniotic exposures to U. parvum) in order to evaluate the difference in the IL-8 concentration and MMP activity between choriodecidual and amniotic compartments. Overall, in untreated controls (without exposure to U. parvum), there was no difference in IL-8 concentration between the choriodecidual or amniotic compartments (P ¼ 0.17). Following exposure to 10 5 CFU U. parvum, IL-8 concentration in the choriodecidual compartment was greater than in the amniotic compartment (P ¼ 0.040). However, this effect disappeared at higher doses of U. parvum exposure (10 6 CFU U. parvum, P ¼ 0.31; 10 7 CFU U. parvum, P ¼ 0.090).
Effects of U. parvum Exposure on MMP-2 and MMP-9 Activity in Gestational Membranes
A representative MMP-2 and MMP-9 zymogram is displayed in Figure 4 . MMP-2 proteolytic activity in both choriodecidual and amniotic compartments increased in a dose-dependent manner upon exposure of the choriodecidua to U. parvum (P ¼ 0.006 and 0.021, respectively; Fig. 5A ). When amnion was exposed to U. parvum, increased MMP-2 proteolytic activity was detected in the amniotic compartment (P ¼ 0.024; Fig. 5B ) but not in the compartment containing the choriodecidua (P ¼ 0.062; Fig. 5B ). MMP-2 proteolytic activity did not significantly vary between the choriodecidual and amniotic compartments when untreated or exposed to U. parvum at any dose (Table 2) .
Proteolytic activity of MMP-9 in the choriodecidual or amniotic compartments did not change upon exposure of the choriodecidua to U. parvum (P ¼ 0.073 and 0.10, respectively; Fig. 6A ). Similarly, following amniotic exposure to U. parvum, no significant change in MMP-9 activity occurred in the amniotic or choriodecidual compartment (P ¼ 0.056 and 0.077, respectively, Fig. 6B ). In untreated controls, there was greater MMP-9 proteolysis in the choriodecidual compartment compared to the amniotic compartment (P ¼ 0.014; Table 3 ). Following exposure to lower doses of U. parvum, this difference between compartments persisted (P ¼ 0.048 and 0.015, respectively), but at the highest dose, there was no difference between compartments with regard to MMP-9 activity (P ¼ 0.41). 
DISCUSSION
Here, we have engineered a novel system whereby intact gestational membranes can be subjected to ex vivo experimentation with sustained tissue viability and without loss of integrity. This dual-chamber system affords the capacity to evaluate the directionality of the effects of U. parvum across the choriodecidua and amnion and thus further elucidate the unique consequences of U. parvum exposure for these distinct layers and its possible contribution to PPROM. This system consists of ordinary, inexpensive materials and does not require significant tissue manipulation, thus facilitating ease of assembly for users and reduction in inflammatory interference that may otherwise be induced by forces required to stretch and secure explants in investigational devices.
Using this system, we demonstrated that U. parvum translocated bidirectionally through intact gestational membranes within a 24 h time course. In particular, following exposure of the amnion, the quantity of bacteria crossing the membranes was dependent on exposure dose, while upon exposure of the choriodecidua, this dose-dependent relationship in bacterial translocation was not observed. These results may be consistent with the hypothesis that PPROM and preterm labor can result from infectious insults from various directions, that is, ascending, transplacental, or iatrogenic passage of pathogens [30] . Alternatively, these data may be interpreted to suggest that the choriodecidua, when exposed to U. parvum, has a limited rate of active transport at which no further bacteria are able to translocate to the amnion. Underlying this hypothesis is the implication that the choriodecidua is able to serve in a protective role for the inner amniotic layer of the membranes and amniotic cavity by restricting active bacterial transport. Additionally, in vivo, there may be factors that serve the physiologic role of inhibiting bacterial proliferation in order to prevent negative consequences for the pregnancy. An important limitation to this research is that, in the setting of tissue explant, bactericidal factors typically found in the amniotic fluid or elsewhere are absent and thus their potentially protective function is precluded.
Interestingly, we detected U. parvum in several untreated control tissues, which most likely represents colonization prior to delivery and aligns with prior data suggesting that the lower genital tract of greater than half of women may be colonized [21] . It is noteworthy that these samples were collected from elective Cesarean deliveries at term and not from pregnancies affected by PPROM, clinical chorioamnionitis, or other obstetric pathology. These results are consistent with previous findings from our laboratory that U. parvum can be recovered from gestational membranes of healthy, term pregnancies, although quantities in pregnancies affected by PPROM are significantly greater [13] . The relationship between the presence of U. parvum in gestational tissues and maternal and neonatal outcomes is beyond the scope of this research but represents a critical translational link in our understanding of the pathogenesis of PPROM and preterm labor.
The inflammatory response of gestational membranes to U. parvum differs between the choriodecidua and the amnion. In particular, we have demonstrated that the amnion responds to increasing U. parvum dose with a gradated increase in IL-8 production, while the choriodecidua produces similar quantities of IL-8 upon exposure to any bacterial load tested in our experiments. The production of IL-8 by the choriodecidua is greater than that by the amnion at a low dose of bacterial exposure. Our data demonstrate that the membrane layers undergo similar dose-dependent responses to U. parvum exposure by upregulating MMP-2 proteolytic activity. In contrast, while we found no dose response of MMP-9 activity in either compartment, the choriodecidua manifested greater MMP-9-mediated proteolysis both in untreated controls and in response to exposure to low doses of U. parvum. Overall, these results support the notion that there may be suppression of inflammatory response to a low quantity of U. parvum as part of the physiologic microbiome, but that upon reaching a critical threshold of bacteria, a pathologic pro-inflammatory state is generated within the gestational membranes. It is important to acknowledge that a significant dose-dependent increase in IL-8 concentration and MMP-2 activity appears to occur in the opposing amniotic compartment in the context of our finding that the choriodecidua may attenuate some translocation of U. parvum across the gestational membranes. This is suggestive of a role for paracrine signaling across gestational membrane layers. This signaling may result in upregulation of proteolytic activity and potentially enhance the pro-inflammatory state induced by U. parvum.
Normal parturition and pathologic conditions entail complex signaling cascades via pro-and anti-inflammatory cytokines, hormones, and various receptors within and across gestational membrane layers. We chose to evaluate IL-8 concentration and MMP activity because cytokine production and enzymatic degradation of collagen may represent critical steps in the inflammatory pathway of PPROM [32] . Of note, MMP proteolysis is critical to tissue remodeling and the apoptotic pathway, which may additionally be activated in the setting of membrane exposure to U. parvum. Future research should entail assessment of pro-apoptotic factors and histologic evaluation in order to further understand the repercussions of U. parvum exposure on the content and structure of the membrane layers.
The consequences of IL-8, MMP-2, and MMP-9 and other inflammatory molecules for the gestational membranes in response to exposure to potential pathogens including U. parvum are poorly understood [16, [33] [34] [35] [36] . One mechanism by which U. parvum may contribute to the induction of IL-8, upregulation of proteolytic enzymes, and potentially rupture of membranes, entails the activation of toll-like receptors-2, -6, and -9 [37] . An additional factor that may contribute to the virulence of U. parvum and the range of obstetric repercussions of these bacteria entails multiple-banded antigen. It has been suggested that variation in this antigen among U. parvum serovars and the host immune response to the antigen, as measured by maternal antibody and pro-inflammatory cytokine levels, may mediate obstetric outcomes [38] . Further evaluation of the specific pathways by which other cytokines and enzymes implicated in the tissue response to U. parvum, in conjunction with the different serovars of U. parvum, provoke inflammation in gestational membranes is warranted. PPROM has been demonstrated in the setting of infection with bacteria other than U. parvum, and polymicrobial infection in particular may contribute to the pro-inflammatory state leading to PPROM. Therefore, additional experimentation with these bacteria is needed to enhance our understanding of the role of U. parvum as only one component within the greater microbial environment to which the gestational tissues are exposed.
This research encompasses the development and validation of a novel dual-chamber tissue explant system by which the pathogenicity of U. parvum in gestational membranes can be evaluated. Our initial evidence supports the hypothesis that U. parvum acts on gestational membranes via the upregulation of IL-8 and MMP-2 activity. Conclusions drawn from this study must take into account the small number of replicates and marked variability across tissue from different subjects. In RESPONSE OF GESTATIONAL MEMBRANES TO U. parvum particular, the possibility of type I or II statistical error cannot be excluded given several P values either just less or greater than the a-level of 0.05. Evaluation of a greater number of samples will yield further insight into the consequences of U. parvum in the different layers of the membranes. Ultimately, we hope that the development of this tissue explant system and addition of data to the growing body of evidence surrounding the role of U. parvum in the gestational membranes will contribute to a greater understanding of the pathogenesis, prevention, and treatment of PPROM and infectious complications of pregnancy.
